LSE:HIK (Hikma Pharmaceuticals PLC)
About HIK
Hikma is an international pharmaceutical company conducting operations through three businesses: generic pharmaceuticals, branded pharmaceuticals and injectable pharmaceuticals. The majority of Hikmas operations are in the United States, the Middle East and North Africa Region and Europe.
Hikma Pharmaceuticals PLC (LSE: HIK) Latest News
Investing Articles
No savings at 40? Here are 5 cheap shares to consider buying in February
Investing Articles
This FTSE 100 stock could be poised for a whopping 40% growth in 2026, or more
Investing Articles
2 FTSE 100 stocks to consider for passive income in 2026
Investing Articles
Down 33%, is there a once-in-a-decade opportunity in this FTSE 100 stock?
Investing Articles
Down 22% with a P/E of 9, is Hikma one of the best passive income picks right now?
Investing Articles
I asked ChatGPT for the best FTSE 100 stock! Here’s what it said…
Investing Articles
I asked ChatGPT for the best FTSE 100 stocks for a rotation out of tech! Here’s what it said
Investing Articles
Late to investing? Don’t worry… here’s how we aim to build a retirement-boosting ISA
Investing Articles
How much do you need in an ISA to target £1,799 in monthly passive income?
Investing Articles
Late to investing? Here are Dr James Fox’s favourite FTSE 100 stocks right now
Investing Articles
2 overlooked UK shares to consider for dividend income